Equities Research Analysts’ Updated EPS Estimates for November 12th (AMGN, APGE, CFBK, COGT, FATE, FCEL, IRON, ITOS, NUVL, ORIC)

Equities Research Analysts’ updated eps estimates for Tuesday, November 12th:

Amgen (NASDAQ:AMGN) had its buy rating reaffirmed by analysts at Jefferies Financial Group Inc.. The firm currently has a $380.00 target price on the stock.

Apogee Therapeutics (NASDAQ:APGE) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $87.00 price target on the stock.

StockNews.com initiated coverage on shares of CF Bankshares (NASDAQ:CFBK). They issued a hold rating on the stock.

Cogent Biosciences (NASDAQ:COGT) had its neutral rating reaffirmed by analysts at Wedbush. They currently have a $11.00 price target on the stock.

Fate Therapeutics (NASDAQ:FATE) had its neutral rating reiterated by analysts at Wedbush. Wedbush currently has a $5.00 target price on the stock.

StockNews.com started coverage on shares of FuelCell Energy (NASDAQ:FCEL). They issued a sell rating on the stock.

Disc Medicine (NASDAQ:IRON) had its outperform rating reiterated by analysts at Wedbush. The firm currently has a $83.00 target price on the stock, up from their previous target price of $75.00.

iTeos Therapeutics (NASDAQ:ITOS) had its outperform rating reaffirmed by analysts at Wedbush. Wedbush currently has a $25.00 price target on the stock.

Nuvalent (NASDAQ:NUVL) had its outperform rating reiterated by analysts at Wedbush. Wedbush currently has a $115.00 price target on the stock.

ORIC Pharmaceuticals (NASDAQ:ORIC) had its outperform rating reissued by analysts at Wedbush. The firm currently has a $20.00 target price on the stock.

StockNews.com began coverage on shares of Power REIT (NYSE:PW). StockNews.com issued a sell rating on the stock.

Sunrun (NASDAQ:RUN) had its hold rating reiterated by analysts at Truist Financial Co.. They currently have a $12.00 price target on the stock, down from their previous price target of $18.00.

Smith Douglas Homes (NYSE:SDHC) had its neutral rating reaffirmed by analysts at Wedbush. They currently have a $20.00 target price on the stock.

Shopify (NYSE:SHOP) (TSE:SHOP) had its neutral rating reissued by analysts at Wedbush. They currently have a $115.00 price target on the stock, up from their previous price target of $72.00.

StockNews.com initiated coverage on shares of TransAct Technologies (NASDAQ:TACT). They issued a hold rating on the stock.

Zeta Global (NYSE:ZETA) had its buy rating reissued by analysts at Truist Financial Co.. They currently have a $42.00 price target on the stock, up from their previous price target of $35.00.